Blinking and Yawning in Epilepsy: The Role of Dopamine

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2014

Conditions
Idiopathic Generalized Epilepsy
Interventions
OTHER

Apomorphine (Experimental product)

"Dosage Form: Injection Dosage: 1 or 5 mg / kg~Route of administration: Subcutaneous~Duration of treatment: two injections of apomorphine followed by two injections of a placebo one week after or vice versa.~Two injections will be made by visiting during visits 2 and 3.~The study was conducted cross-over with two visits EEG recording, the order will be randomized injections:~* Sequence A during visit 2 followed by sequence B during visit 3~* or sequence B during visit 2"

Trial Locations (1)

38700

CIC Department - University Hospital of Grenoble, La Tronche

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01432821 - Blinking and Yawning in Epilepsy: The Role of Dopamine | Biotech Hunter | Biotech Hunter